UnitedHealth Group (UNH) which is traded on the New York Stock Exchange, is a healthcare company that aims to help everyone live a healthier life and make the health system work better. UnitedHealth Group offers a wide range of products and services through two different platforms, namely UnitedHealthcare, which provides health protection and benefits services, and Optum, which provides information technology services in healthcare. UNH will report its 3rd quarter financial report on Thursday October 14, 2021, before the market opens.
In its Q2 earnings report published last July, UNH reported stronger growth and more diversity. The economic recovery and increasing demand for healthcare showed an encouraging recovery in 2021 after it experienced a decline in demand during the movement restrictions at the beginning of the Covid-19 pandemic. UNH reported revenue increased 15% to $71.30 billion. Return per share (EPS) in the 2nd quarter was reported at $4.70 (versus the $4.43 projection). Overall, UNH reported consistent sales and EPS results and has exceeded analyst projections over the past four quarterly reports, and it is expected to once again report positive financial results for the third quarter.
Market analysts at Zacks project UNH to be among the companies with the potential to sustain growth and release encouraging financial reports in the 3rd quarter following UNH’s history of consistently surpassing market analysts’ projections. Based on projections from CNN Business, UNH analysts’ consensus projections are expected to report sales revenue of $71.3 billion in the 3rd quarter, unchanged from the 2nd quarter, while the EPS consensus is for $4.41, down slightly by -6.9% from the previous quarter. The annual EPS projection for 2021 is expected at $18.75, up from $16.88 in 2020 (an increase of 11.09%).
SUMBER: CNN Business
Technical Analysis #UnitedHealth (MT5)
Shares of #UnitedHealth have shown an encouraging rise in 2021, recording the highest price level in its history at 431.36, a 35% increase from the lowest price of 2021 in January at 320.00. This increase is in line with the increase in the major US bourses, namely US30 and US500, which also recorded increases. But now it is down a bit at 402.97, slightly below the daily MA50. The 382.88 level (Oct 1 low) is the nearest support.
CNN Business forecasts put #UnitedHealth shares as expected to rise for the next 12 months with the median price at 465.00, the highest projection at 522.00 while the low projection is 421.00. 23 analysts place the stock in the BUY rating category with only one placing the stock “underperform”.
Click here to access our Economic Calendar
Tunku Ishak Al-Irsyad
Market Analyst
Disclaimer: This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.
